Compound information
- Natural Products
- ZC2458100
- Molecular Formula
- C26H39N3O5
- Molecular Weight
- 473.288971348 g/mol
- Structure
-
- IUPAC Name
- benzyl N-[(1S)-1-[[(1S)-1-[[(1S)-1-formyl-3-methyl-but-3-enyl]carbamoyl]-3-methyl-butyl]carbamoyl]-3-methyl-butyl]carbamate
- InChI
- InChI=1S/C26H39N3O5/c1-17(2)12-21(15-30)27-24(31)22(13-18(3)4)28-25(32)23(14-19(5)6)29-26(33)34-16-20-10-8-7-9-11-20/h7-11,15,18-19,21-23H,1,12-14,16H2,2-6H3,(H,27,31)(H,28,32)(H,29,33)/t21-,22-,23-/m0/s1
- InChI Key
- ZXWQFMXXHLZICN-VABKMULXSA-N
- SMILES
- C=C(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1
- Source
- ZINC000003826240
Warheads
- Carbamate
-
- Aldehydic carbonyl
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 34 | Ring Count | 1 |
Heteroatom Count | 8 | Rotatable Bond Count | 14 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 3 |
Topological Polar Surface Area | 113.6 Å2 | LogP | 4.186 |
LogS | -4.463 | LogD | 4.343 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.992 | Pgp substrate | 0.45 |
HIA | 0.792 | F20 % | 0.986 |
F30 % | 0.095 | Caco-2 | -4.671 |
MDCK | -4.805 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.19 | PPB | 79.765 |
VD | 0.514 | Fu | 1.388 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.008 | CYP1A2 substrate | 0.616 |
CYP2A6 substrate | 0.35 | CYP2B6 substrate | 0.552 |
CYP2C19 inhibitor | 0.33 | CYP2C19 substrate | 0.983 |
CYP2C8 substrate | 0.727 | CYP2C9 inhibitor | 0.049 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.021 |
CYP2D6 substrate | 0.679 | CYP2E1 substrate | 0.233 |
CYP3A4 inhibitor | 0.194 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.808 | CL | 9.221 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.007 | Hepatotoxicity | 0.959 |
Mutagenicity | 0.213 | Rat Oral Acute Toxicity | 0.261 |
FDAMDD | 0.503 | Skin Sensitization | 0.501 |
Carcinogenicity | 0.039 | Eye Corrosion | 0.013 |
Eye Irritation | 0.024 | Respiratory Toxicity | 0.024 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -0.864 | IGC50 | 3.762 |
LC50FM | 4.214 | LC50DM | 5.592 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.125 | NR-AR-LBD | 0.31 |
NR-AhR | 0.007 | NR-Aromatase | 0.041 |
NR-ER | 0.389 | NR-ER-LBD | 0.34 |
NR-PPAR-gamma | 0.512 | SR-ARE | 0.621 |
SR-ATAD5 | 0.311 | SR-HSE | 0.221 |
SR-MMP | 0.158 | SR-p53 | 0.029 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.